Morris Innovative Names Eamonn Hobbs to Board of Directors

MedTech Industry Leader Eamonn Hobbs Will Serve As Chairman of the Board for Morris Innovative

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
When Morris Innovative invited me to join the board, I saw an opportunity to help the company advance the treatment of cardiovascular disease.

Bloomington, IN (PRWEB) February 24, 2014

Morris Innovative, a medical device company focused on innovative vascular closure device systems based in Bloomington, Indiana, today announces that medical technology executive Eamonn P. Hobbs has been appointed Chairman of the company’s Board of Directors.

“Eamonn Hobbs brings to Morris Innovative a wealth of industry contacts and successful operating experience,” said John Morris, CEO of Morris. “Given Eamonn’s 30-plus years of identifying and commercializing a wide variety of innovative medical technologies, we are looking forward to his contributions as Morris moves into the commercial phase of our development.”

“When Morris Innovative invited me to join the board, I saw an opportunity to help the company advance the treatment of cardiovascular disease through their unique vascular closure products, CombiClose and the very recently introduced ControlClose,” said Hobbs. “Morris Innovative has already made a name for themselves among health care practitioners in the cardiovascular and peripheral disease space with their unique products. I look forward to working with the Board and management to maximize the Company’s opportunities.”

Mr. Hobbs brings to Morris Innovative more than 30 years of leadership experience in a number of medical technology industry segments including interventional radiology, oncology, interventional cardiology, surgery, gastroenterology and medical device/pharmaceutical combination products. After graduating from the University of Massachusetts-Lowell in 1980 with a degree in Plastics Engineering, Mr. Hobbs immediately set out and went to work as a Product Development Engineer with Cook Incorporated. He co-founded AngioDynamics in 1988 and served as the Company’s President and CEO until 2008. During his tenure, he built the Company into a global market leader with more than $200 million in sales and 700 employees. In 2009 he transitioned from Delcath Systems, Inc. Board of Directors member to become President and CEO and served as Chairman on the Medical Device Manufacturers Association (MDMA) Board of Directors from 2010 to 2013.

In addition to Morris Innovative, Mr. Hobbs is a member of the Board of Directors of Antares Pharmaceuticals; Harmonic Medical, Inc. the MDMA and the Glens Falls (NY) Hospital.

About Morris Innovative
Morris Innovative is a medical device company based in Bloomington, Indiana that is commercializing a patented device for use by interventional cardiologists, radiologists, and vascular surgeons. Our products, CombiClose and the very recently introduced ControlClose provide vascular closure for patients undergoing treatment for cardiovascular and peripheral disease. With over 30,000 sold in the US, CombiClose is the only combination working sheath/closure device. The very recently introduced ControlClose is a more standard exchange closure system. Both of the devices incorporate an introducer sheath with a pre-mounted biologic material (Small Intestinal Submucosa, “SIS”) which is used to seal and promote rapid healing of the common femoral artery following a catheterization procedure. CombiClose and ControlClose also deliver unsurpassed safety by allowing the clinician to completely be in control of the closure process. The product received Premarket Approval (PMA) from the FDA in August 2007 and a subsequent approval in July 2008 due to multiple design enhancements. For more information, log on to http://www.morrisinnovative.com.


Contact

  • David Schemelia
    EVC Group
    +1 646-201-5431
    Email